[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Nimodipine Market Report 2016

September 2016 | 111 pages | ID: U6C679C0D62EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Nimodipine

Revenue, means the sales value of Nimodipine

This report studies sales (consumption) of Nimodipine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Bayer
  • Sun Pharmaceutical
  • Boai Pharmaceutical
  • Yabao Group
  • Central Pharm
  • Ruikang Pharmaceutical
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Nimodipine in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Nimodipine Market Report 2016

1 NIMODIPINE OVERVIEW

1.1 Product Overview and Scope of Nimodipine
1.2 Classification of Nimodipine
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Nimodipine
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Nimodipine (2011-2021)
  1.4.1 United States Nimodipine Sales and Growth Rate (2011-2021)
  1.4.2 United States Nimodipine Revenue and Growth Rate (2011-2021)

2 UNITED STATES NIMODIPINE COMPETITION BY MANUFACTURERS

2.1 United States Nimodipine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Nimodipine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Nimodipine Average Price by Manufactures (2015 and 2016)
2.4 Nimodipine Market Competitive Situation and Trends
  2.4.1 Nimodipine Market Concentration Rate
  2.4.2 Nimodipine Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES NIMODIPINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Nimodipine Sales and Market Share by Type (2011-2016)
3.2 United States Nimodipine Revenue and Market Share by Type (2011-2016)
3.3 United States Nimodipine Price by Type (2011-2016)
3.4 United States Nimodipine Sales Growth Rate by Type (2011-2016)

4 UNITED STATES NIMODIPINE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Nimodipine Sales and Market Share by Application (2011-2016)
4.2 United States Nimodipine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES NIMODIPINE MANUFACTURERS PROFILES/ANALYSIS

5.1 Bayer
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Nimodipine Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Bayer Nimodipine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Sun Pharmaceutical
  5.2.2 Nimodipine Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Sun Pharmaceutical Nimodipine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Boai Pharmaceutical
  5.3.2 Nimodipine Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Boai Pharmaceutical Nimodipine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Yabao Group
  5.4.2 Nimodipine Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Yabao Group Nimodipine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Central Pharm
  5.5.2 Nimodipine Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Central Pharm Nimodipine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Ruikang Pharmaceutical
  5.6.2 Nimodipine Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Ruikang Pharmaceutical Nimodipine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview

6 NIMODIPINE MANUFACTURING COST ANALYSIS

6.1 Nimodipine Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Nimodipine

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Nimodipine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Nimodipine Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES NIMODIPINE MARKET FORECAST (2016-2021)

10.1 United States Nimodipine Sales, Revenue Forecast (2016-2021)
10.2 United States Nimodipine Sales Forecast by Type (2016-2021)
10.3 United States Nimodipine Sales Forecast by Application (2016-2021)
10.4 Nimodipine Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Nimodipine
Table Classification of Nimodipine
Figure United States Sales Market Share of Nimodipine by Type in 2015
Table Application of Nimodipine
Figure United States Sales Market Share of Nimodipine by Application in 2015
Figure United States Nimodipine Sales and Growth Rate (2011-2021)
Figure United States Nimodipine Revenue and Growth Rate (2011-2021)
Table United States Nimodipine Sales of Key Manufacturers (2015 and 2016)
Table United States Nimodipine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Nimodipine Sales Share by Manufacturers
Figure 2016 Nimodipine Sales Share by Manufacturers
Table United States Nimodipine Revenue by Manufacturers (2015 and 2016)
Table United States Nimodipine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Nimodipine Revenue Share by Manufacturers
Table 2016 United States Nimodipine Revenue Share by Manufacturers
Table United States Market Nimodipine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Nimodipine Average Price of Key Manufacturers in 2015
Figure Nimodipine Market Share of Top 3 Manufacturers
Figure Nimodipine Market Share of Top 5 Manufacturers
Table United States Nimodipine Sales by Type (2011-2016)
Table United States Nimodipine Sales Share by Type (2011-2016)
Figure United States Nimodipine Sales Market Share by Type in 2015
Table United States Nimodipine Revenue and Market Share by Type (2011-2016)
Table United States Nimodipine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Nimodipine by Type (2011-2016)
Table United States Nimodipine Price by Type (2011-2016)
Figure United States Nimodipine Sales Growth Rate by Type (2011-2016)
Table United States Nimodipine Sales by Application (2011-2016)
Table United States Nimodipine Sales Market Share by Application (2011-2016)
Figure United States Nimodipine Sales Market Share by Application in 2015
Table United States Nimodipine Sales Growth Rate by Application (2011-2016)
Figure United States Nimodipine Sales Growth Rate by Application (2011-2016)
Table Bayer Basic Information List
Table Bayer Nimodipine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Nimodipine Sales Market Share (2011-2016)
Table Sun Pharmaceutical Basic Information List
Table Sun Pharmaceutical Nimodipine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceutical Nimodipine Sales Market Share (2011-2016)
Table Boai Pharmaceutical Basic Information List
Table Boai Pharmaceutical Nimodipine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boai Pharmaceutical Nimodipine Sales Market Share (2011-2016)
Table Yabao Group Basic Information List
Table Yabao Group Nimodipine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Yabao Group Nimodipine Sales Market Share (2011-2016)
Table Central Pharm Basic Information List
Table Central Pharm Nimodipine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Central Pharm Nimodipine Sales Market Share (2011-2016)
Table Ruikang Pharmaceutical Basic Information List
Table Ruikang Pharmaceutical Nimodipine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ruikang Pharmaceutical Nimodipine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nimodipine
Figure Manufacturing Process Analysis of Nimodipine
Figure Nimodipine Industrial Chain Analysis
Table Raw Materials Sources of Nimodipine Major Manufacturers in 2015
Table Major Buyers of Nimodipine
Table Distributors/Traders List
Figure United States Nimodipine Production and Growth Rate Forecast (2016-2021)
Figure United States Nimodipine Revenue and Growth Rate Forecast (2016-2021)
Table United States Nimodipine Production Forecast by Type (2016-2021)
Table United States Nimodipine Consumption Forecast by Application (2016-2021)


More Publications